What barriers still limit access to advanced AA therapies? @pfizer
What barriers still limit access to advanced AA therapies?  @pfizer
Uploaded December 2025 | Updated September 2026, 2 weeks ago
Equity in AA Care: Stories and Insights in Alopecia Areata is a multi-part video series that explores the experience of alopecia areata from diagnosis to treatment access, and the policy environment. In our third video, Alessandro Monaco speaks with Dr Leila Asfour and patient advocates Carlotta Sezzi, Jonas Labermeier, and Jean-Marie Meurant as they share perspectives on differences in treatment access across Italy, Germany, France and the UK. The panelists share a range of barriers to accessing treatment for severe alopecia areata across Italy, Germany, France and the UK. These include limited patient information, gaps in healthcare professional education, and insufficient support after consultations. They also note the perception of alopecia areata as cosmetic rather than autoimmune continues to limit reimbursement and timely care.
What barriers still limit access to advanced AA therapies?What is modality?New Frontiers in AI & Drug Discovery | Science Will Win Podcast Season 4 | Episode 4Science Made Simple: Cancer BiomarkersWhat is a plate reader & how does it work?What is a T-cell engager?Building a Greater Future Together | Edith Cooper | The Power of Knowing with Lidia FonsecaWIML Part 3: Visualization using microscopyWhat is it like trying to get access to Alopecia Areata treatment?Antibody selection processWIML: Purifying mixtures with a rotovapAlex Shares His Story Of A Loved One
Pfizer |

What barriers still limit access to advanced AA therapies?

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER